Companies /Healthcare

Pfizer Inc

NYSE: PFE Drug Manufacturers - General
$28.32
▼ $0.25 (−0.88%) today
Markets closed · 6:17pm ET

PFE Coverage

Page 62
4:01pm ET
Investing

The 4 Stocks That Sank the DJIA on Monday

thinkstockSeptember 28, 2015: Markets opened lower on Monday following a report that personal income rose just 0.3% in August, short of the expected 0.5% economists were looking for. Personal spending rose and personal…

Paul Ausick
4:01pm ET
Investing

The 4 Stocks That Lifted the Dow on Thursday

thinkstockSeptember 10, 2015: Markets opened lower on Thursday after a rather lackluster performance in Asia’s equity markets and more of the same in Europe. Initial claims for unemployment benefits were in line…

Paul Ausick
4:01pm ET
Investing

The 4 Stocks That Lifted the DJIA Higher Tuesday

thinkstockSeptember 8, 2015: Markets opened higher on Tuesday following reports that the Chinese government would pump more liquidity into the equity market. China’s trade data was mixed: the balance rose more than…

Paul Ausick
4:01pm ET
Investing

The 4 Stocks That Hobbled the Dow on Monday

thinkstockAugust 31 2015: Markets opened lower on Monday, but even a massive rally in crude oil couldn’t keep the bears at bay. A somewhat vague bulletin from OPEC and an EIA report…

Paul Ausick
4:01pm ET
Investing

The 4 Stocks That Held Down the DJIA on Friday

thinkstockAugust 28, 2015: Markets opened lower on Friday, and except for a brief visit above the break-even line, the blue chips traded lower all day. Crude oil settled at $45.22, up more…

Paul Ausick
2:09pm ET
Health and Healthcare

Pfizer Gets Approval For Hospira Acquisition

ThinkstockAt a time when there is pressure on how large US companies are making domestic or overseas acquisitions are coming under more scrutiny, Pfizer Inc. (NYSE:PFE) announced on Monday that the Federal…

PFE
Jon C. Ogg
10:50am ET
Investing

4 Event-Driven Stocks to Buy for the Rest of 2015

A new research note from Jefferies lists stocks that could have meaningful events soon. The stocks in some cases have sold off significantly, and the analysts view fundamental downside as limited.

Lee Jackson